NEWTON, Mass.--(BUSINESS WIRE)--Matritech, Inc. (Amex: MZT) announced that, in connection with the proposed acquisition by Inverness Medical Innovations, Inc. (Amex: IMA) of substantially all of Matritech’s assets, Inverness yesterday filed an initial Registration Statement on Form S-4 that includes a preliminary proxy statement for a special meeting of the Matritech stockholders. This Registration Statement remains subject to review by the Securities and Exchange Commission and is available at: http://sec.gov/Archives/edgar/data/1145460/000104746907007831/ a2180136zs-4.htm. (Due to the length of this URL, it may be necessary to copy and paste it into your Internet browser’s URL address field. You may also need to remove an extra space in the URL if one exists.)
